Vedana Therapeutics

United States · Biotech · Healthtech

Develops next-generation therapies for migraine prevention

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$46MAlexandria Venture Investments — Role not disclosedCanaan Partners — Role not disclosedDawn Biopharma — Role not disclosedWestlake BioPartners — Role not disclosed
Sourcesvedanatx.com ↗